172 related articles for article (PubMed ID: 20386060)
1. LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma.
Shoji N; Nakagawa K; Asai A; Fujita I; Hashiura A; Nakajima Y; Oikawa S; Miyazawa T
J Lipid Res; 2010 Aug; 51(8):2445-53. PubMed ID: 20386060
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of blood lipid glycation and lipid oxidation in diabetic patients.
Suzuki K; Nakagawa K; Miyazawa T
Clin Chem Lab Med; 2014 Jan; 52(1):47-52. PubMed ID: 23454716
[TBL] [Abstract][Full Text] [Related]
3. Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes.
Nakagawa K; Oak JH; Higuchi O; Tsuzuki T; Oikawa S; Otani H; Mune M; Cai H; Miyazawa T
J Lipid Res; 2005 Nov; 46(11):2514-24. PubMed ID: 16150834
[TBL] [Abstract][Full Text] [Related]
4. A UPLC-MRM-MS method for comprehensive profiling of Amadori compound-modified phosphatidylethanolamines in human plasma.
He X; Li Z; Zhang Q
Anal Bioanal Chem; 2021 Jan; 413(2):431-443. PubMed ID: 33111151
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Identification of Amadori Compound-Modified Phosphatidylethanolamines in Human Plasma.
He X; Chen GY; Zhang Q
Chem Res Toxicol; 2019 Jul; 32(7):1449-1457. PubMed ID: 31188577
[TBL] [Abstract][Full Text] [Related]
6. Analysis of amadori-glycated phosphatidylethanolamine in the plasma of healthy subjects and diabetic patients by liquid chromatography-tandem mass spectrometry.
Miyazawa T; Ibusuki D; Yamashita S; Nakagawa K
Ann N Y Acad Sci; 2008 Apr; 1126():291-4. PubMed ID: 18448834
[TBL] [Abstract][Full Text] [Related]
7. Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes--influence of glycation products on lipid peroxidation.
Breitling-Utzmann CM; Unger A; Friedl DA; Lederer MO
Arch Biochem Biophys; 2001 Jul; 391(2):245-54. PubMed ID: 11437356
[TBL] [Abstract][Full Text] [Related]
8. Tandem mass spectrometry analysis of Amadori-glycated phosphatidylethanolamine in human plasma.
Miyazawa T; Oak JH; Nakagawa K
Ann N Y Acad Sci; 2005 Jun; 1043():280-3. PubMed ID: 16037249
[TBL] [Abstract][Full Text] [Related]
9. Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats.
Sookwong P; Nakagawa K; Fujita I; Shoji N; Miyazawa T
Lipids; 2011 Oct; 46(10):943-52. PubMed ID: 21732214
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of glycated phosphatidylethanolamines: evidence of oxidation in glycated polar head identified by LC-MS/MS.
Simões C; Simões V; Reis A; Domingues P; Domingues MR
Anal Bioanal Chem; 2010 Jul; 397(6):2417-27. PubMed ID: 20499053
[TBL] [Abstract][Full Text] [Related]
11. Identification of deoxy-D-fructosyl phosphatidylethanolamine as a non-enzymic glycation product of phosphatidylethanolamine and its occurrence in human blood plasma and red blood cells.
Lertsiri S; Shiraishi M; Miyazawa T
Biosci Biotechnol Biochem; 1998 May; 62(5):893-901. PubMed ID: 9648220
[TBL] [Abstract][Full Text] [Related]
12. Identification and quantification of aminophospholipid-linked Maillard compounds in model systems and egg yolk products.
Utzmann CM; Lederer MO
J Agric Food Chem; 2000 Apr; 48(4):1000-8. PubMed ID: 10775341
[TBL] [Abstract][Full Text] [Related]
13. Free advanced glycation end product distribution in blood components and the effect of genetic polymorphisms.
Nomi Y; Kudo H; Miyamoto K; Okura T; Yamamoto K; Shimohiro H; Kitao S; Ito Y; Egawa S; Kawahara K; Otsuka Y; Ueta E
Biochimie; 2020 Dec; 179():69-76. PubMed ID: 32946992
[TBL] [Abstract][Full Text] [Related]
14. Isolation and identification of glycated aminophospholipids from red cells and plasma of diabetic blood.
Ravandi A; Kuksis A; Marai L; Myher JJ; Steiner G; Lewisa G; Kamido H
FEBS Lett; 1996 Feb; 381(1-2):77-81. PubMed ID: 8641444
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatography-tandem mass spectrometry determination of human plasma 1-palmitoyl-2-hydroperoxyoctadecadienoyl-phosphatidylcholine isomers via promotion of sodium adduct formation.
Kato S; Nakagawa K; Suzuki Y; Asai A; Nagao M; Nagashima K; Oikawa S; Miyazawa T
Anal Biochem; 2015 Feb; 471():51-60. PubMed ID: 25447492
[TBL] [Abstract][Full Text] [Related]
16. Lipid glycation and protein glycation in diabetes and atherosclerosis.
Miyazawa T; Nakagawa K; Shimasaki S; Nagai R
Amino Acids; 2012 Apr; 42(4):1163-70. PubMed ID: 20957396
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects.
Zhang Q; Monroe ME; Schepmoes AA; Clauss TR; Gritsenko MA; Meng D; Petyuk VA; Smith RD; Metz TO
J Proteome Res; 2011 Jul; 10(7):3076-88. PubMed ID: 21612289
[TBL] [Abstract][Full Text] [Related]
18. Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor.
Higuchi O; Nakagawa K; Tsuzuki T; Suzuki T; Oikawa S; Miyazawa T
J Lipid Res; 2006 May; 47(5):964-74. PubMed ID: 16470027
[TBL] [Abstract][Full Text] [Related]
19. Determination of nonpolar and polar lipid classes in human plasma, erythrocytes and plasma lipoprotein fractions using ultrahigh-performance liquid chromatography-mass spectrometry.
Holčapek M; Cífková E; Červená B; Lísa M; Vostálová J; Galuszka J
J Chromatogr A; 2015 Jan; 1377():85-91. PubMed ID: 25543301
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of ɛ-N-carboxymethyl-L-lysine in human plasma by liquid chromatography-tandem mass spectrometry.
Kuang L; Jing Z; Wang J; Ma L; Liu X; Yang J
J Pharm Biomed Anal; 2014 Mar; 90():1-6. PubMed ID: 24317023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
